Venture Capital Investment | Plutus Investment Group

Menu
  • Home
  • About Us
  • Our Portfolio
  • News
Contact Us

News

April 3, 2023

Oxford Cancer Biomarkers closes funding round led by Plutus Investment Group LLP

January 11, 2023

MPC Therapeutics Announces Completion of Its CHF 1.5M Seed-Funding Round to Improve CAR-T Cancer Therapies.

April 5, 2022

Channel 4 to bring cannabis brand Cannaray to TV

February 11, 2022

Leaf Logistics Wants to be the Air Traffic Control for Ground Transportation

January 27, 2022

SiSaf Announces Michael J. Econs MD, World-leading Expert in Metabolic Bone Disease, as Clinical Advisor

January 18, 2022

Mobile app helps Multiple Sclerosis patients by quantifying neurologic function

January 17, 2022

DTF medical, Adecco Medical et Biospeedia s’allient pour le dépistage du Covid

September 16, 2021

Michaël Zouzou Joins BayBridgeDigital as Head of Solutions to Accelerate Company’s Growth

April 22, 2021

Adverttu Offers UK’s First Carbon Neutral Transit Media Advertising

Heading Link
Menu
  • Home
  • About Us
  • Our Portfolio
  • News
Socials
  • Linkedin
Address

Level 1, Devonshire House, One Mayfair PI, London W1J 8AJ


Phone: +44 2032054817

  • info@plutus-investment.com

©2022 by Plutus Investment Group LLP 17 Hannover Square, London, W1S 1BN

Menu